Role of matrix metalloproteinases in apoptosis after transient focal cerebral ischemia in rats and mice

European Journal of Neuroscience

Volumn 22, Issue 7, 2005, Pages 1597-1608

  Copin, Jean Christophe ^a   Goodyear, Marie Christelle ^a   Gidday, Jeffrey M ^b   Shah, Aarti R ^b   Gascon, Eduardo ^a   Dayer, Alexandre ^a   Morel, Denis M ^a   Gasche, Yvan ^a  

^a UNIVERSITY OF GENEVA MEDICAL SCHOOL   (Switzerland)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Blood brain barrier; CH6631; Stroke

Indexed keywords

4 [[3 (4 PHENOXYLPHENOXY)PROPYLSULFONYL]METHYL]TETRAHYDROPYRAN 4 CARBOXYLIC ACID N HYDROXYAMIDE; CALPAIN; DNA FRAGMENT; FODRIN; HYDROXAMIC ACID DERIVATIVE; MATRIX METALLOPROTEINASE; MATRIX METALLOPROTEINASE INHIBITOR; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BRAIN INFARCTION; BRAIN ISCHEMIA; CONTROLLED STUDY; CYTOSOL; DISEASE MODEL; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME RELEASE; GENE; GENE TARGETING; MMP9 GENE; MOUSE; MOUSE STRAIN; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; RAT; SIGNAL DETECTION;

ANIMALS; APOPTOSIS; BLOTTING, WESTERN; BRAIN ISCHEMIA; CALPAIN; CASPASE 3; CASPASES; CELL COUNT; CYTOCHROMES C; DISEASE MODELS, ANIMAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FUNCTIONAL LATERALITY; HYDROXAMIC ACIDS; IN SITU NICK-END LABELING; INJECTIONS, INTRAVENTRICULAR; INTERLEUKIN-1; MATRIX METALLOPROTEINASE 9; MATRIX METALLOPROTEINASES; MEMBRANE GLYCOPROTEINS; MICE; MICE, KNOCKOUT; RATS; RATS, SPRAGUE-DAWLEY; STAINING AND LABELING; SUBCELLULAR FRACTIONS; SULFONAMIDES;

EID: 26944468648     PISSN: 0953816X     EISSN: 14609568     Source Type: Journal    
DOI: 10.1111/j.1460-9568.2005.04367.x     Document Type: Article

References (48)

1. Asahi, M., Sumii, T., Fini, M.E., Itohara, S. & Lo, E.H. (2001a) Matrix metalloproteinase 2 gene knockout has no effect on acute brain injury after focal ischemia. Neuroreport, 12, 3003-3007.
2. Asahi, M., Wang, X., Mon, T., Sumii, T., Jung, J.C., Moskowitz, M.A., Fini, M.E. & Lo, E.H. (2001b) Effects of matrix metalloproteinase-9 gene knockout on the proteolysis of blood-brain barrier and white matter components after cerebral ischemia. J. Neurosci., 21, 7724-7732.
3. Blomgren, K., Zhu, C., Wang, X., Karlsson, J.O., Leverin, A.L., Bahr, B.A., Mallard, C. & Hagberg, H. (2001) Synergistic activation of caspase-3 by m-calpain after neonatal hypoxia-ischemia: a mechanism of 'pathological apoptosis'? J. Biol. Chem., 276, 10191-10198.
4. Cardone, M.H., Salvesen, G.S., Widmann, C., Johnson, G. & Frisch, S.M. (1997) The regulation of anoikis: MEKK-1 activation requires cleavage by caspases. Cell, 90, 315-323.
5. Chen, Y., Ginis, I. & Hallenbeck, J.M. (2001) The protective effect of ceramide in immature rat brain hypoxia-ischemia involves up-regulation of bcl-2 and reduction of TUNEL-positive cells. J. Cereb. Blood Flow Metab., 21, 34-40.
6. Ferri, K.F. & Kroemer, G. (2001) Mitochondria - the suicide organelles. Bioessays, 23, 111-115.
7. Fujimura, M., Gasche, Y., Morita-Fujimura, Y., Massengale, J., Kawase, M. & Chan, P.H. (1999a) Early appearance of activated matrix metalloproteinase-9 and blood-brain barrier disruption in mice after focal cerebral ischemia and reperfusion. Brain Res., 842, 92-100.
8. Fujimura, M., Morita-Fujimura, Y., Kawase, M., Copin, J.C., Calagui, B., Epstein, C.J. & Chan, P.H. (1999b) Manganese superoxide dismutase mediates the early release of mitochondrial cytochrome C and subsequent DNA fragmentation after permanent focal cerebral ischemia in mice. J. Neurosci., 19, 3414-3422.
9. Fujimura, M., Morita-Fujimura, Y., Murakami, K., Kawase, M. & Chan, P.H. (1998) Cytosolic redistribution of cytochrome c after transient focal cerebral ischemia in rats. J. Cereb. Blood Flow Metab., 18, 1239-1247.
10. Fujimura, M., Morita-Fujimura, Y., Narasimhan, P., Copin, J.C., Kawase, M. & Chan, P.H. (1999c) Copper-zinc superoxide dismutase prevents the early decrease of apurinic/apyrimidinic endonuclease and subsequent DNA fragmentation after transient focal cerebral ischemia in mice. Stroke, 30, 2408-2415.
11. Gasche, Y., Copin, J.C., Sugawara, T., Fujimura, M. & Chan, P.H. (2001) Matrix metalloproteinase inhibition prevents oxidative stress-associated blood-brain barrier disruption after transient focal cerebral ischemia. J. Cereb. Blood Flow Metab., 21, 1393-1400.
12. Gasche, Y., Fujimura, M., Morita-Fujimura, Y., Copin, J.C., Kawase, M., Massengale, J. & Chan, P.H. (1999) Early appearance of activated matrix metalloproteinase-9 after focal cerebral ischemia in mice: a possible role in blood-brain barrier dysfunction. J. Cereb. Blood Flow Metab., 19, 1020-1028.
13. Gidday, J.M., Gasche, Y.G., Copin, J.C., Shah, A.R., Perez, R.S., Shapiro, S.D., Chan, P.H. & Park, T.S. (2005) Leukocyte-derived matrix metalloproteinase-9 mediates blood-brain barrier breakdown and is proinflammatory following transient focal cerebral ischemia. Am. J. Physiol. Heart Circ. Physiol., 289, H558-H568.
14. Ginsberg, M.D., Becker, D.A., Busto, R., Belayev, A., Zhang, Y., Khoutorova, L., Ley, J.J., Zhao, W. & Belayev, L. (2003) Stilbazulenyl nitrone, a novel antioxidant, is highly neuroprotective in focal ischemia. Ann. Neurol., 54, 330-342.
15. Goldlust, E.J., Paczynski, R.P., He, Y.Y., Hsu, C.Y. & Goldberg, M.P. (1996) Automated measurement of infarct size with scanned images of triphenyltetrazolium chloride-stained rat brains. Stroke, 27, 1657-1662.
16. Graham, S.H. & Chen, J. (2001) Programmed cell death in cerebral ischemia. J. Cereb Blood Flow Metab., 21, 99-109.
17. Gu, Z., Kaul, M., Yan, B., Kridel, S.J., Cui, J., Strongin, A., Smith, J.W., Liddington, R.C. & Lipton, S.A. (2002) S-nitrosylation of matrix metalloproteinases: signaling pathway to neuronal cell death. Science, 297, 1186-1190.
18. Hampton, D.W., Seitz, A., Chen, P., Heber-Katz, E. & Fawcett, J.W. (2004) Altered CNS response to injury in the MRL/MpJ mouse. Neuroscience, 127, 821-832.
19. Hojilla, C.V., Mohammed, F.F. & Khokha, R. (2003) Matrix metalloproteinases and their tissue inhibitors direct cell fate during cancer development. Br. J. Cancer, 89, 1817-1821.
20. Jiang, S.T., Wang, J.H., Chang, T. & Chen, C.S. (1997) A continuous method for measuring calpain activity. Anal. Biochem., 244, 233-238.
21. Kwan, J.A., Schulze, C.J., Wang, W., Leon, H., Sariahmetoglu, M., Sung, M., Sawicka, J., Sims, D.E., Sawicki, G. & Schulz, R. (2004) Matrix metalloproteinase-2 (MMP-2) is present in the nucleus of cardiac myocytes and is capable of cleaving poly (ADP-ribose) polymerase (PARP) in vitro. Faseb J., 18, 690-692.
22. Lee, S.R. & Lo, E.H. (2004) Induction of caspase-mediated cell death by matrix metalloproteinases in cerebral endothelial cells after hypoxia-reoxygenation. J. Cereb. Blood Flow Metab., 24, 720-727.
23. Lee, S.R., Tsuji, K. & Lo, E.H. (2004) Role of matrix metalloproteinases in delayed neuronal damage after transient global cerebral ischemia. J. Neurosci., 24, 671-678.
24. Leeman, M.F., Curran, S. & Murray, G.I. (2003) New insights into the roles of matrix metalloproteinases in colorectal cancer development and progression. J. Pathol., 201, 528-534.
25. Leker, R.R. & Shohami, E. (2002) Cerebral ischemia and trauma-different etiologies yet similar mechanisms: neuroprotective opportunities. Brain Res. Brain Res. Rev., 39, 55-73.
26. Lewen, A., Fujimura, M., Sugawara, T., Matz, P., Copin, J.C. & Chan, P.H. (2001) Oxidative stress-dependent release of mitochondrial cytochrome c after traumatic brain injury. J. Cereb. Blood Flow Metab., 21, 914-920.
27. Lipton, P. (1999) Ischemic cell death in brain neurons. Physiol. Rev., 79, 1431-1568.
28. Loetscher, H., Niederhauser, O., Kemp, J. & Gill, R. (2001) Is caspase-3 inhibition a valid therapeutic strategy in cerebral ischemia? Drug Discov. Today, 6, 671-680.
29. Lynch, C.C. & Matrisian, L.M. (2002) Matrix metalloproteinases in tumor-host cell communication. Differentiation, 70, 561-573.
30. Madesh, M. & Hajnoczky, G. (2001) VDAC-dependent permeabilization of the outer mitochondrial membrane by superoxide induces rapid and massive cytochrome c release. J. Cell Biol., 155, 1003-1015.
31. McCawley, L.J. & Matrisian, L.M. (2001) Matrix metalloproteinases: they're not just for matrix anymore! Curr. Opin. Cell Biol., 13, 534-540.
32. Montana, J.G., Baxter, A.D., Owen, D.A. & Watson, R.J. (1999) Preparation of tetrahydropyran-4-carboxylates as matrix metalloproteinase inhibitor. WO 99/40080A1 (patent).
33. Nakagawa, T. & Yuan, J. (2000) Cross-talk between two cysteine protease families. Activation of caspase-12 by calpain in apoptosis. J. Cell Biol., 150, 887-894.
34. Nath, R., Raser, K.J., Stafford, D., Hajimohammadreza, I., Posner, A., Allen, H., Talanian, R.V., Yuen, P., Gilbertsen, R.B. & Wang, K.K. (1996) Non-erythroid alpha-spectrin breakdown by calpain and interleukin 1 beta-converting-enzyme-like protease (s) in apoptotic cells: contributory roles of both protease families in neuronal apoptosis. Biochem. J., 319, 683-690.
35. Ramamurthy, N.S., Xu, J.W., Bird, J., Baxter, A., Bhogal, R., Wills, R., Watson, B., Owen, D., Wolff, M. & Greenwald, R.A. (2002) Inhibition of alveolar bone loss by matrix metalloproteinase inhibitors in experimental periodontal disease. J. Periodontal Res., 37, 1-7.
36. Rami, A. (2003) Ischemic neuronal death in the rat hippocampus: the calpain-calpastatin-caspase hypothesis. Neurobiol. Dis., 13, 75-88.
37. Rami, A., Agarwal, R., Botez, G. & Winckler, J. (2000) mu-Calpain activation, DNA fragmentation, and synergistic effects of caspase and calpain inhibitors in protecting hippocampal neurons from ischemic damage. Brain Res., 866, 299-312.
38. Rosenberg, G.A. (2002) Matrix metalloproteinases in neuroinflammation. Glia, 39, 279-291.
39. Schonbeck, U., Mach, F. & Libby, P. (1998) Generation of biologically active IL-1 beta by matrix metalloproteinases: a novel caspase-1-independent pathway of IL-1 beta processing. J. Immunol., 161, 3340-3346.
40. Szabo, C. & Dawson, V.L. (1998) Role of poly (ADP-ribose) synthetase in inflammation and ischaemia-reperfusion. Trends Pharmacol. Sci., 19, 287-298.
41. Touzani, O., Boutin, H., Chuquet, J. & Rothwell, N. (1999) Potential mechanisms of interleukin-1 involvement in cerebral ischaemia. J. Neuroimmunol., 100, 203-215.
42. Vogelstein, B., Lane, D. & Levine, A.J. (2000) Surfing the p53 network. Nature, 408, 307-310.
43. Vu, T.H., Shipley, J.M., Bergers, G., Berger, J.E., Helms, J.A., Hanahan, D., Shapiro, S.D., Senior, R.M. & Werb, Z. (1998) MMP-9/gelatinase B is a key regulator of growth plate angiogenesis and apoptosis of hypertrophic chondrocytes. Cell, 93, 411-422.
44. Wang, K.K. (2000) Calpain and caspase: can you tell the difference? Trends Neurosci., 23, 20-26.
45. Wang, H., Yu, S.W., Koh, D.W., Lew, J., Coombs, C., Bowers, W., Federoff, H.J., Poirier, G.G., Dawson, T.M. & Dawson, V.L. (2004) Apoptosis-inducing factor substitutes for caspase executioners in NMDA-triggered excitotoxic neuronal death. J. Neurosci., 24, 10963-10973.
46. Wetzel, M., Rosenberg, G.A. & Cunningham, L.A. (2003) Tissue inhibitor of metalloproteinases-3 and matrix metalloproteinase-3 regulate neuronal sensitivity to doxorubicin-induced apoptosis. Eur. J. Neurosci., 18, 1050-1060.
47. Yong, V.W., Power, C., Forsyth, P. & Edwards, D.R. (2001) Metalloproteinases in biology and pathology of the nervous system. Nat. Rev. Neurosci., 2, 502-511.
48. Yu, S.W., Wang, H., Dawson, T.M. & Dawson, V.L. (2003) Poly (ADP-ribose) polymerase-1 and apoptosis inducing factor in neurotoxicity. Neurobiol. Dis., 14, 303-317.